Side-by-side financials for EDSA and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EDSA | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$7.19M | - |
| SEC filings | 713 | 1,004 |
Full pages: Edesa Biotech, Inc. and AstraZeneca PLC, or browse the full rankings.